Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

288.24
-3.2600-1.12%
Post-market: 289.341.10+0.38%19:30 EDT
Volume:1.09M
Turnover:312.29M
Market Cap:13.76B
PE:-59.05
High:291.41
Open:285.91
Low:284.34
Close:291.50
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.22
T/O Rate:2.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.85
PE(LYR):-98.98

Loading ...

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 29

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 25

Charles River Laboratories International Inc. Stock Slides 9.2%, Underperforms Peers

Dow Jones
·
Apr 24

AbbVie receives CRL from FDA regarding BLA for trenibotulinumtoxinE

TIPRANKS
·
Apr 24

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

GlobeNewswire
·
Apr 24

Revvity Falls 15.5%, Bio-Techne Drops 10.1%, IQVIA Drops 8.3%, Charles River Down 7%

THOMSON REUTERS
·
Apr 23

Shares of Biotech and Medical Equipment Cos Fall After Thermo Fisher Results, Outlook

THOMSON REUTERS
·
Apr 23

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 22

Charles River reports results of restrospective analysis on VCGs in toxicology

TIPRANKS
·
Apr 21

Charles River analysis finds virtual control groups match NOAEL outcomes in toxicology studies

Reuters
·
Apr 21

Is Cheaper Energy and Shipping Altering The Investment Case For Charles River Laboratories (CRL)?

Simply Wall St.
·
Apr 20

GPT-Rosalind Sparks CRO Sector Slump: Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact?

TradingKey
·
Apr 17

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Apr 17

Charles River Labs sets first-quarter earnings release, conference call

Reuters
·
Apr 16

Charles River Labs : Barclays Raises Target Price to $210 From $200

THOMSON REUTERS
·
Apr 15

Charles River Labs Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15

Charles River Laboratories Positioned as 'Leading' CRO as Preclinical R&D Inflection Nears, RBC Says

MT Newswires Live
·
Apr 14

RBC Initiates Charles River Laboratories International at Outperform With $215 Price Target

MT Newswires Live
·
Apr 14

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 14

FDA Rejection Sparks Questions On Replimune Drug Approval Path

Benzinga_recent_news
·
Apr 14